- Home
- Labeler Index
- Swedish Orphan Biovitrum Ab (publ)
- 66658-523
- NDC Crossover: 66658-523 Gamifant
NDC Crossover 66658-523 Gamifant
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Emapalumab
Explore similar products and medications to NDC 66658-523 Gamifant a human prescription drug with other products crossover matching the same product name (Gamifant) or generic name (Emapalumab-lzsg), and the same administration route (intravenous) or dosage form (injection). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 66658-501 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-505 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-510 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-522 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-524 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-525 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |